The Food and Drug Administration (FDA) has ordered companies that produce cough medicine containing guaifenesin in timed-release formula to cease production and shipping before the end of 2007. Guaifenesin is a substance that stimulates the removal of mucous from the lungs in cough and cold sufferers.
Advanced Medical Optics has announced a recall of Complete MoisturePLUS Multipurpose Solution, a product used for cleaning and storing soft contact lenses. The solution has been linked to Acanthamoeba keratitis (AK), an infection that causes deteriorating vision. Some sufferers require a corneal transplant, while other AK sufferers may even go blind.
The Food and Drug Administration (FDA) may have released a safety alert on May 21, 2007 for Avandia – but that’s not the first time the agency has been concerned about this dangerous diabetes drug. As far back as 2002, the FDA has known that Avandia may cause heart attacks and death in patients, including many with no previous history of heart failure.
Recent research has found a link between mothers that take Depakote, an epilepsy drug, and metal retardation in toddlers. Children exposed to Depakote while still in the womb were twice as likely to test within the range associated with mental retardation at the ages of two to three years old.
If you are one of over 6 million people worldwide who take the GlaxoSmithKline diabetes drug Avandia, you may be putting yourself at a greater risk for a heart attack or even worse, death. Results of over a dozen studies have shown a 43 percent greater risk of heart attack and a 64 percent greater risk of heart-related death in those who have taken the drug.
Attention parents – your teenager’s cell phone may be the most dangerous hazard on the road. A recent insurance survey found that teens say texting is their #1 distraction on the roadways. Another recent study found that over one-third of all young drivers send text messages while driving, with one-fifth of all drivers texting at the wheel of their cars.
Are the very drugs used by cancer patients to help them get better actually making them worse? A panel of government safety advisors with the Food and Drug Administration (FDA) thinks so. Aranesp and Procrit, used to treat anemia in chemotherapy patients, pose the risk of advancing cancer and shortening the lives of users.
OxyContin manufacturer Purdue Pharma and the company’s top executives have agreed to pay settlement fees in excess of $650 million to the Federal government, 26 states, and the District of Columbia. OxyContin is a prescription opioid pain reliever that has been under fire for marketing that failed to warn about the drug's extremely addictive and abusive qualities.
Fosamax, a leading osteoporosis drug, has been connected to problems with irregular heart rhythm. Along with Reclast, another bone-building drug, atrial fibrillation developed much higher in test groups that took the medications.
Attention anyone 18 to 24 taking Prozac, Paxil, or any antidepressant drugs – beware of the dangerous risks of suicidal thoughts and behaviors during initial treatment. The Food and Drug Administration (FDA) has proposed that every variety of antidepressant medication update their current black box labels to include warning of heightened risk of suicide in young adults beginning treatment.
A warning to consumers seeking prescription drugs at a discounted rate – beware of online sellers that may be peddling fake or mislabeled medication. The Food and Drug Administration (FDA) has released a statement regarding recent cases of counterfeit prescription drugs being sold by Pharmacycall365.com and 24 other related websites.